OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of mRNA vaccine against Omicron-related infections in the real world: A systematic review and meta-analysis
Kaixin Guo, Peng Ni, Shuailei Chang, et al.
American Journal of Infection Control (2023) Vol. 51, Iss. 9, pp. 1049-1055
Closed Access | Times Cited: 7
Kaixin Guo, Peng Ni, Shuailei Chang, et al.
American Journal of Infection Control (2023) Vol. 51, Iss. 9, pp. 1049-1055
Closed Access | Times Cited: 7
Showing 7 citing articles:
Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis
Obaidur Rahman, Taro Kamigaki, Moe Moe Thandar, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e076892-e076892
Open Access | Times Cited: 14
Obaidur Rahman, Taro Kamigaki, Moe Moe Thandar, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e076892-e076892
Open Access | Times Cited: 14
An overview of lipid constituents in lipid nanoparticle mRNA delivery systems
Shiqi Wu, Lixin Lin, Lu Shi, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 4
Shiqi Wu, Lixin Lin, Lu Shi, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 4
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
Haruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 213-225
Open Access | Times Cited: 3
Haruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 213-225
Open Access | Times Cited: 3
Engineered mRNA Delivery Systems for Biomedical Applications
Ji Wang, Haofang Zhu, Jingjing Gan, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 9
Ji Wang, Haofang Zhu, Jingjing Gan, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 9
Relative effectiveness and durability of booster doses of SARS-CoV-2 vaccines: A systematic review and meta-analysis
Di Liu, Yi-Wen Jiang, Shiyu Wang, et al.
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100051-100051
Open Access | Times Cited: 1
Di Liu, Yi-Wen Jiang, Shiyu Wang, et al.
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100051-100051
Open Access | Times Cited: 1
Design of the conserved epitope peptide of SARS-CoV-2 spike protein as the broad-spectrum COVID-19 vaccine
Ting‐Yu Chang, Chia‐Jung Li, Tai‐Ling Chao, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 1
Ting‐Yu Chang, Chia‐Jung Li, Tai‐Ling Chao, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 1
Viral infections, an overview with a focus on prevention of transmission
Shuk‐Ching Wong, Kelvin Hei‐Yeung Chiu, Cyril Chik‐Yan Yip, et al.
Elsevier eBooks (2024), pp. 165-181
Closed Access
Shuk‐Ching Wong, Kelvin Hei‐Yeung Chiu, Cyril Chik‐Yan Yip, et al.
Elsevier eBooks (2024), pp. 165-181
Closed Access
